1004754-99-7 Usage
Uses
Used in Pharmaceutical Industry:
(2S)-2-(2,6-Dichlorophenyl)-1-[(1R)-1-phenylethyl]-4-imidazolidinone is used as a potential pharmaceutical agent due to its imidazolidinone core, which is known to possess various pharmacological activities. Its unique stereochemistry and functional groups may contribute to its efficacy in treating specific medical conditions, although the exact applications are yet to be determined through further research.
Used in Biological Research:
In the field of biological research, (2S)-2-(2,6-Dichlorophenyl)-1-[(1R)-1-phenylethyl]-4-imidazolidinone may serve as a valuable compound for studying the effects of stereochemistry on biological activity. Its chiral nature allows for investigations into how different configurations impact interactions with biological targets, potentially leading to the development of more effective and selective drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 1004754-99-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,4,7,5 and 4 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1004754-99:
(9*1)+(8*0)+(7*0)+(6*4)+(5*7)+(4*5)+(3*4)+(2*9)+(1*9)=127
127 % 10 = 7
So 1004754-99-7 is a valid CAS Registry Number.
1004754-99-7Relevant academic research and scientific papers
NOVEL IMIDAZOLIDINONE DERIVATIVE, METHOD OF PRODUCING THE SAME AND METHOD OF PRODUCING OPTICALLY ACTIVE AMINO ACID
-
Page/Page column 27, (2009/05/29)
The objective of the present invention is to provide an optically active imidazolidinone derivative widely usable for synthesizing an optically active amino acid, a method of easily producing the derivative, and a method of easily producing an optically active amino acid by using the derivative. The objective can be achieved by producing an optically active amino acid using a novel optically active imidazolidinone derivative represented by a general formula (3) and the like. According to the method of the present invention, an optically active imidazolidinone derivative can be obtained by preferential crystallization from a mixture of isomers of the imidazolidinone derivative. Therefore, an optically active amino acid can be easily and stereoselectively produced without cumbersome procedures required for the conventional methods, such as resolution of diastereomers, synthesis from an optically active amino acid and resolution of isomers by silica gel column cromatography.
